Harmony Biosciences Holdings Inc (HRMY)
33.43
+0.39
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
33.00
-0.43
(-1.29%)
After-Hours: 18:13
Harmony Biosciences Holdings Price: 33.43 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 33.47 | 34.50 | 32.78 | 33.04 | 886467.0 |
| Nov 01, 2024 | 32.50 | 34.11 | 31.48 | 33.08 | 5.294M |
| Oct 31, 2024 | 31.26 | 33.64 | 31.02 | 32.13 | 4.995M |
| Oct 30, 2024 | 37.49 | 38.00 | 33.50 | 33.80 | 2.888M |
| Oct 29, 2024 | 37.58 | 41.61 | 36.23 | 41.49 | 1.317M |
| Oct 28, 2024 | 34.83 | 35.80 | 34.63 | 35.75 | 809748.0 |
| Oct 25, 2024 | 34.10 | 34.90 | 33.91 | 34.50 | 450754.0 |
| Oct 24, 2024 | 34.00 | 34.50 | 33.80 | 34.05 | 394385.0 |
| Oct 23, 2024 | 34.80 | 34.98 | 33.84 | 34.05 | 381801.0 |
| Oct 22, 2024 | 34.61 | 35.29 | 34.61 | 34.86 | 392595.0 |
| Oct 21, 2024 | 35.37 | 35.44 | 34.63 | 34.95 | 731796.0 |
| Oct 18, 2024 | 35.13 | 35.43 | 34.81 | 35.41 | 671222.0 |
| Oct 17, 2024 | 34.97 | 35.37 | 34.63 | 34.97 | 431709.0 |
| Oct 16, 2024 | 35.56 | 35.80 | 34.72 | 34.84 | 456417.0 |
| Oct 15, 2024 | 35.43 | 35.91 | 35.25 | 35.50 | 444893.0 |
| Oct 14, 2024 | 34.93 | 36.16 | 34.93 | 35.48 | 296255.0 |
| Oct 11, 2024 | 34.54 | 35.42 | 34.41 | 34.83 | 476217.0 |
| Oct 10, 2024 | 34.00 | 35.14 | 33.61 | 34.81 | 565424.0 |
| Oct 09, 2024 | 34.73 | 35.04 | 33.56 | 33.60 | 357752.0 |
| Oct 08, 2024 | 34.49 | 34.91 | 33.83 | 34.75 | 1.637M |
| Oct 07, 2024 | 34.57 | 34.75 | 33.38 | 34.38 | 508137.0 |
| Oct 04, 2024 | 34.93 | 35.07 | 34.23 | 34.60 | 387445.0 |
| Oct 03, 2024 | 35.76 | 35.88 | 34.60 | 34.77 | 736308.0 |
| Oct 02, 2024 | 39.22 | 39.62 | 35.25 | 35.57 | 1.025M |
| Oct 01, 2024 | 40.55 | 40.60 | 38.17 | 39.24 | 442857.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
19.20
Minimum
Oct 27 2023
60.91
Maximum
Dec 05 2022
37.84
Average
35.95
Median
Sep 18 2023
Price Benchmarks
| Regeneron Pharmaceuticals Inc | 829.32 |
| EyePoint Pharmaceuticals Inc | 11.61 |
| Cassava Sciences Inc | 23.92 |
| Capricor Therapeutics Inc | 18.44 |
| Anavex Life Sciences Corp | 7.685 |
Price Related Metrics
| PE Ratio | 15.84 |
| PS Ratio | 2.844 |
| Price to Book Value | 3.195 |
| Price to Free Cash Flow | 8.808 |
| Earnings Yield | 6.31% |
| Market Cap | 1.907B |
| Operating PE Ratio | 11.06 |
| Normalized PE Ratio | 15.84 |